ReviewFrontiers in aging neuroscience2025
Motor symptoms of Parkinson's disease: critical markers for early AI-assisted diagnosis.
Review in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care.Journal of Parkinson's disease · 2026Review
- Quantitative susceptibility mapping and MRS-based multimodal machine learning for early Parkinson's disease classification.NPJ Parkinson's disease · 2026Article
- Machine learning classification of early-stage Parkinson's disease using sit-to-walk biomechanical features.Scientific reports · 2026Article
- Physiological Functions of Side-Chain-Retaining Sterols in the Brain and Their Roles in Neurodegenerative Diseases.Metabolites · 2026Review
- Parkinson's Disease: Conventional Pharmacotherapy, Drug Delivery Innovations, and Emerging Therapeutic Targets.Brain sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease is a prevalent neurodegenerative disorder, where early diagnosis is essential for slowing disease progression and optimizing treatment strategies. The latest developments in artificial intelligence (AI) have introduced new opportunities for early detection. Studies have demonstrated that before obvious motor symptoms appear, PD patients exhibit a range of subtle but quantifiable motor abnormalities. This article provides an overview of AI-driven early detection approaches based on various motor symptoms of PD, including eye movement, facial expression, speech, handwriting, finger tapping, and gait. Specifically, we summarized the characteristic manifestations of these motor symptoms, analyzed the features of the data currently collected for AI-assisted diagnosis, collected the publicly available datasets, evaluated the performance of existing diagnostic models, and discussed their limitations. By scrutinizing the existing research methodologies, this review summarizes the application progress of motor symptom-based AI technology in the early detection of PD, explores the key challenges from experimental techniques to clinical translation applications, and proposes future research directions to promote the clinical practice of AI technology in PD diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.